Notice Information
Notice Title
Procurement of Lutetium (177Lu) oxodetreotide (Luthathera) PRRT
Notice Description
Procurement of Lutetium (177Lu) oxodetreotide (Luthathera) PRRT
Procurement Information
No other reasonable alternative or substitute exists for this procurement and the absence of competition is not a result of the artificial narrowing of the parameters of the procurement. Lutetium (177Lu) oxodetreotide (Lutathera) is a licensed radiopharmaceutical for the treatment of unresectable or metastatic, progressive, well-differentiated somatostatin receptor positive gastro-entero-pancreatic neuroendocrine (GEP) tumours in adults. The supplier, Advanced Accelerator Applications (AAA), holds the unique patent and licence for this product. This is the only licenced Peptide Receptor Radionuclide Therapy (PRRT) in Europe
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-034401
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/017908-2022
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33000000 - Medical equipments, pharmaceuticals and personal care products
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £3,000,000 £1M-£10M
Notice Dates
- Publication Date
- 30 Jun 20223 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 7 Jun 20223 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- BELFAST HEALTH AND SOCIAL CARE TRUST
- Contact Name
- Norma Moore
- Contact Email
- norma.moore@belfasttrust.hscni.net
- Contact Phone
- Not specified
Buyer Location
- Locality
- BELFAST
- Postcode
- BT9 7AB
- Post Town
- Northern Ireland
- Country
- Northern Ireland
-
- Major Region (ITL 1)
- TLN Northern Ireland
- Basic Region (ITL 2)
- TLN0 Northern Ireland
- Small Region (ITL 3)
- TLN06 Belfast
- Delivery Location
- TLN Northern Ireland
-
- Local Authority
- Belfast
- Electoral Ward
- Blackstaff
- Westminster Constituency
- Belfast South and Mid Down
Further Information
Notice URLs
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-034401-2022-06-30T14:44:33+01:00",
"date": "2022-06-30T14:44:33+01:00",
"ocid": "ocds-h6vhtk-034401",
"initiationType": "tender",
"tender": {
"id": "DAC10464",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Procurement of Lutetium (177Lu) oxodetreotide (Luthathera) PRRT",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33000000",
"description": "Medical equipments, pharmaceuticals and personal care products"
},
"mainProcurementCategory": "goods",
"description": "Procurement of Lutetium (177Lu) oxodetreotide (Luthathera) PRRT",
"lots": [
{
"id": "1",
"description": "Procurement of Lutetium (177Lu) oxodetreotide (Luthathera) PRRT",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
},
"hasOptions": false,
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UKN"
},
{
"region": "UKN"
}
],
"deliveryLocation": {
"description": "Belfast Health and Social Care Trust"
},
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"id": "D_PROTECT_RIGHTS",
"description": "The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights"
}
],
"procurementMethodRationale": "No other reasonable alternative or substitute exists for this procurement and the absence of competition is not a result of the artificial narrowing of the parameters of the procurement. Lutetium (177Lu) oxodetreotide (Lutathera) is a licensed radiopharmaceutical for the treatment of unresectable or metastatic, progressive, well-differentiated somatostatin receptor positive gastro-entero-pancreatic neuroendocrine (GEP) tumours in adults. The supplier, Advanced Accelerator Applications (AAA), holds the unique patent and licence for this product. This is the only licenced Peptide Receptor Radionuclide Therapy (PRRT) in Europe"
},
"awards": [
{
"id": "015707-2022-DAC10464-1",
"relatedLots": [
"1"
],
"title": "Procurement of Lutetium (177Lu) oxodetreotide (Luthathera) PRRT",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-52394",
"name": "Advanced Accelerator Applications (UK & Ireland) Ltd"
}
]
},
{
"id": "017908-2022-DAC10464-1",
"relatedLots": [
"1"
],
"title": "Procurement of Lutetium (177Lu) oxodetreotide (Luthathera) PRRT",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-52394",
"name": "Advanced Accelerator Applications (UK & Ireland) Ltd"
}
]
}
],
"parties": [
{
"id": "GB-FTS-4486",
"name": "BELFAST HEALTH AND SOCIAL CARE TRUST",
"identifier": {
"legalName": "BELFAST HEALTH AND SOCIAL CARE TRUST"
},
"address": {
"streetAddress": "LISBURN ROAD",
"locality": "BELFAST",
"region": "UKN06",
"postalCode": "BT97AB",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Norma Moore",
"email": "norma.moore@belfasttrust.hscni.net"
},
"roles": [
"buyer"
],
"details": {
"url": "https://belfasttrust.hscni.net",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-52394",
"name": "Advanced Accelerator Applications (UK & Ireland) Ltd",
"identifier": {
"legalName": "Advanced Accelerator Applications (UK & Ireland) Ltd"
},
"address": {
"streetAddress": "Edison House, 223-231 Old Marylebone Road",
"locality": "London",
"region": "UKI",
"postalCode": "NW1 1QT",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"url": "http://www.adacap.com",
"scale": "large"
}
},
{
"id": "GB-FTS-37142",
"name": "Belfast Health and Social Care Trust",
"identifier": {
"legalName": "Belfast Health and Social Care Trust"
},
"address": {
"locality": "Belfast",
"postalCode": "BT8 8BH",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "norma.moore@belfasttrust.hscni.net"
},
"roles": [
"reviewBody"
],
"details": {
"url": "https://belfasttrust.hscni.net"
}
}
],
"buyer": {
"id": "GB-FTS-4486",
"name": "BELFAST HEALTH AND SOCIAL CARE TRUST"
},
"contracts": [
{
"id": "015707-2022-DAC10464-1",
"awardID": "015707-2022-DAC10464-1",
"title": "Procurement of Lutetium (177Lu) oxodetreotide (Luthathera) PRRT",
"status": "active",
"value": {
"amount": 3000000,
"currency": "GBP"
},
"dateSigned": "2022-06-08T00:00:00+01:00"
},
{
"id": "017908-2022-DAC10464-1",
"awardID": "017908-2022-DAC10464-1",
"title": "Procurement of Lutetium (177Lu) oxodetreotide (Luthathera) PRRT",
"status": "active",
"value": {
"amount": 3000000,
"currency": "GBP"
},
"dateSigned": "2022-06-30T00:00:00+01:00"
}
],
"language": "en",
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
}
]
}
}